Navigation Links
Jarrow Formulas Launches New Products Featuring BioCell Collagen II(R)
Date:10/4/2007

The two new products, Skin Optimizer and Hyaluronic Acid Complex, promote

skin and joint health benefits.

ANAHEIM, Calif., Oct. 4 /PRNewswire/ -- Jarrow Formulas, recognized in July by Nutrition Business Journal, selected BioCell Collagen II -- a patented and clinically supported natural ingredient to enhance the effectiveness of two new Jarrow Formulas products -- Skin Optimizer and Hyaluronic Acid Complex. The new formulations featuring BioCell Collagen II supply a naturally occurring matrix of bioavailable hydrolyzed collagen type II, hyaluronic acid (HA) and chondroitin sulfate (CS), and is made in the United States under strict quality control guidelines. As components of cartilage, this natural form is essential in promoting cartilage growth and the appearance of youthful skin.

"Jarrow Formulas joins the elite class of reputable companies that use BioCell Collagen II in their formulas," said Suhail Ishaq, vice president of BioCell Technology, LLC. "Once again, consumers can feel assured that they are receiving only the highest quality ingredients that they would expect from an industry leader such as Jarrow Formulas."

Jarrow Formulas Skin Optimizer is an advanced skin care formula with BioCell Collagen II and other highly effective supporting nutrients that have been shown clinically to enhance skin integrity.

Jarrow Formulas Hyaluronic Acid Complex provides the fluid matrix for joint lubrication, skin hydration, and skin repair. Unlike ordinary collagen products, patented BioCell Collagen II is a rich source of bioavailable hyaluronic acid and is clinically proven to support joint health. Each capsule provides 50mg of bioavailable hyaluronic acid.

Jarrow Formulas, Inc. is a nutritional supplement formulator and marketer founded in 1977 and incorporated in 1988. Jarrow Formulas, Inc. is active in regulatory affairs, helping to maintain Americans' rights to free access to dietary supplements. For more information, contact Mark Becker, director, advertising/communications, toll-free at (800) 726-0886 or access the Jarrow Formulas Web site at http://www.Jarrow.com.

Founded in 1997, BioCell Technology, LLC owns the exclusive rights to license BioCell Collagen II under the United States Patents #6,025,327, 6,323,319, 6,780,841, other U.S. and foreign patents pending. BioCell Collagen II is a branded dietary ingredient that is available to dietary supplement and functional foods manufacturers to market under their own brand name or formulas. For more information on BioCell Collagen II, contact Suhail Ishaq at BioCell Technology, LLC at (714) 632-1231, or visit http://www.biocelltechnology.com.


'/>"/>
SOURCE BioCell Technology, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Merge launches diagnostic mammography workstation in Europe
2. Einstein Wireless launches cellular alert system
3. Logistics Health launches compliance management tool
4. UW-Madison launches new high-speed research network
5. UWM launches research foundation
6. TeraMedica launches information manager
7. GE Healthcare launches hybrid electronic record
8. Cedara launches new version of DICOM toolkit
9. Merge launches Spanish version of imaging tool
10. Doyle launches 2025 alternative energy plan
11. Jellyfish launches comparative shopping website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... findings on what they believe could be a new and helpful biomarker for ... research. Click here to read it now. , Biomarkers are components ...
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
Breaking Biology Technology:
(Date:6/2/2016)... 2016 The Department of Transport Management ... 44 million US Dollar project, for the , ... Personalization, Enrolment, and IT Infrastructure , to ... and implementation of Identity Management Solutions. Numerous renowned international vendors ... Decatur was selected for the most compliant and ...
(Date:5/24/2016)... care by providing unparalleled technology to leaders of the medical imaging industry.  As such, ... to the range of products distributed by Ampronix. Photo - http://photos.prnewswire.com/prnh/20160524/371420 ... ... ... With ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
Breaking Biology News(10 mins):